PAULA SY: Open Payments
NPI 1871281535 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,933 in 106 payments from 15 companies in 2025. Trend: 2023 $944 · 2024 $2,283 · 2025 $1,933
Food & beverage: $1,848Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $542 |
| Janssen Biotech, Inc. | 23 | $324 |
| PFIZER INC. | 15 | $247 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $199 |
| GENZYME CORPORATION | 13 | $152 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $96 |
| Lilly USA, LLC | 4 | $89 |
| Madrigal Pharmaceuticals | 2 | $58 |
| Phathom Pharmaceuticals, Inc. | 4 | $58 |
| Ipsen Biopharmaceuticals, Inc | 2 | $52 |
Products named: SKYRIZI, TREMFYA, VELSIPITY, XIFAXAN, DUPIXENT, OMVOH, ENTYVIO, RINVOQ.
Industry payments across NV — which companies pay providers there.
